Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Proc Natl Acad Sci U S A
2000 Jul 18;9715:8590-3. doi: 10.1073/pnas.97.15.8590.
Show Gene links
Show Anatomy links
Calsenilin reverses presenilin-mediated enhancement of calcium signaling.
Leissring MA
,
Yamasaki TR
,
Wasco W
,
Buxbaum JD
,
Parker I
,
LaFerla FM
.
???displayArticle.abstract???
Most cases of autosomal-dominant familial Alzheimer's disease are linked to mutations in the presenilin genes (PS1 and PS2). In addition to modulating beta-amyloid production, presenilin mutations also produce highly specific and selective alterations in intracellular calcium signaling. Although the molecular mechanisms underlying these changes are not known, one candidate molecular mediator is calsenilin, a recently identified calcium-binding protein that associates with the C terminus of both PS1 and PS2. In this study, we investigated the effects of calsenilin on calcium signaling in Xenopus oocytes expressing either wild-type or mutant PS1. In this system, mutant PS1 potentiated the amplitude of calcium signals evoked by inositol 1,4,5-trisphosphate and also accelerated their rates of decay. We report that calsenilin coexpression reverses both of these potentially pathogenic effects. Notably, expression of calsenilin alone had no discernable effects on calcium signaling, suggesting that calsenilin modulates these signals by a mechanism independent of simple calcium buffering. Our findings further suggest that the effects of presenilin mutations on calcium signaling are likely mediated through the C-terminal domain, a region that has also been implicated in the modulation of beta-amyloid production and cell death.
An,
Modulation of A-type potassium channels by a family of calcium sensors.
2000, Pubmed,
Xenbase
An,
Modulation of A-type potassium channels by a family of calcium sensors.
2000,
Pubmed
,
Xenbase
Bezprozvanny,
Bell-shaped calcium-response curves of Ins(1,4,5)P3- and calcium-gated channels from endoplasmic reticulum of cerebellum.
1991,
Pubmed
Buxbaum,
Calsenilin: a calcium-binding protein that interacts with the presenilins and regulates the levels of a presenilin fragment.
1998,
Pubmed
Callamaras,
Caged inositol 1,4,5-trisphosphate for studying release of Ca2+ from intracellular stores.
1998,
Pubmed
,
Xenbase
Carrión,
DREAM is a Ca2+-regulated transcriptional repressor.
1999,
Pubmed
Clark,
The role of presenilin 1 in the genetics of Alzheimer's disease.
1996,
Pubmed
Etcheberrigaray,
Calcium responses in fibroblasts from asymptomatic members of Alzheimer's disease families.
1998,
Pubmed
Gibson,
Altered oxidation and signal transduction systems in fibroblasts from Alzheimer patients.
1996,
Pubmed
Guo,
Alzheimer's PS-1 mutation perturbs calcium homeostasis and sensitizes PC12 cells to death induced by amyloid beta-peptide.
1996,
Pubmed
Guo,
Alzheimer's presenilin mutation sensitizes neural cells to apoptosis induced by trophic factor withdrawal and amyloid beta-peptide: involvement of calcium and oxyradicals.
1997,
Pubmed
Guo,
Calbindin D28k blocks the proapoptotic actions of mutant presenilin 1: reduced oxidative stress and preserved mitochondrial function.
1998,
Pubmed
Guo,
Increased vulnerability of hippocampal neurons to excitotoxic necrosis in presenilin-1 mutant knock-in mice.
1999,
Pubmed
Ito,
Internal Ca2+ mobilization is altered in fibroblasts from patients with Alzheimer disease.
1994,
Pubmed
Leissring,
Presenilin-2 mutations modulate amplitude and kinetics of inositol 1, 4,5-trisphosphate-mediated calcium signals.
1999,
Pubmed
,
Xenbase
Leissring,
Capacitative calcium entry deficits and elevated luminal calcium content in mutant presenilin-1 knockin mice.
2000,
Pubmed
Leissring,
Alzheimer's presenilin-1 mutation potentiates inositol 1,4,5-trisphosphate-mediated calcium signaling in Xenopus oocytes.
1999,
Pubmed
,
Xenbase
Mattson,
Calcium signaling in the ER: its role in neuronal plasticity and neurodegenerative disorders.
2000,
Pubmed
Mattson,
Effects of elevated intracellular calcium levels on the cytoskeleton and tau in cultured human cortical neurons.
1991,
Pubmed
Mattson,
Presenilins, the endoplasmic reticulum, and neuronal apoptosis in Alzheimer's disease.
1998,
Pubmed
Meyers,
Calcium-dependent translocation of sorcin to membranes: functional relevance in contractile tissue.
1995,
Pubmed
Meyers,
Sorcin associates with the pore-forming subunit of voltage-dependent L-type Ca2+ channels.
1998,
Pubmed
Querfurth,
Calcium ionophore increases amyloid beta peptide production by cultured cells.
1994,
Pubmed
Selkoe,
Translating cell biology into therapeutic advances in Alzheimer's disease.
1999,
Pubmed
Sun,
A continuum of InsP3-mediated elementary Ca2+ signalling events in Xenopus oocytes.
1998,
Pubmed
,
Xenbase
Thinakaran,
Endoproteolysis of presenilin 1 and accumulation of processed derivatives in vivo.
1996,
Pubmed
Tomita,
C terminus of presenilin is required for overproduction of amyloidogenic Abeta42 through stabilization and endoproteolysis of presenilin.
1999,
Pubmed
Vito,
Requirement of the familial Alzheimer's disease gene PS2 for apoptosis. Opposing effect of ALG-3.
1996,
Pubmed
Weber,
Presenilin-1 immunoreactivity is localized intracellularly in Alzheimer's disease brain, but not detected in amyloid plaques.
1997,
Pubmed